Podcast by Talking Urology
Hazard ratios are so last century: the new measures of success with the IO agents
Prof Thomas Powles joins Talking Urology to discuss the new measures of success with IO agents.
A/Prof Shahrokh Shariat - Talking Urology Podcast
A/Prof Shariat is currently professor and chairman of the department of urology, Medical University of Vienna General Hospital, Austria.
He is also adjunct professor of urology and medical oncology at Weill Cornell Medical Center, New York, and adjunct professor or urology at the University of Texas Southwestern Medical Center, Dallas, USA.
Dr Hendrik Van Poppel - Talking Urology Podcast
Prof Van Poppel is the Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium. He is a Board Member of the European Association of Urology (EAU), the European Society of Surgical Oncology and the European Organization for Research and Treatment of Cancer, where he is also Study Coordinator and Treasurer of the Genito-Urinary Group. He is Chairman of the Educational Office of the EAU and Director of the European School of Urology.
Talking Urology and Raiders of the Lost CRPC featuring Neal Shore and Ben Tran
Join the star-studded cast of Talking Urology with Neal Shore, Ben Tran and Joseph Ischia as they unearth the mysteries of non-metastatic CRPC
Dr Laurie Klotz - Talking Urology Podcast
Dr. Klotz is the founding editor of the Canadian Urology Association Journal and is now the Editor Emeritus. He is chairman of the Canadian Urology Research Consortium and is a widely published uro-oncologist with over 300 publications and 4 books.
His main research interest has been prostate cancer and was awarded the Queen’s Jubilee Medal for meritorious public service.
Dr Daniel Lin - Talking Urology Podcast
Dr. Lin is Professor and Chief of Urologic Oncology in the Department of Urology and holds the Bridges Endowed Professorship for Prostate Cancer Research at the University of Washington School of Medicine.
Dr. Lin’s major basic/translational research interests are in prostate chemoprevention and molecular/genomic biomarkers for aggressive prostate cancer, and his major clinical research efforts are in prostate cancer active surveillance and novel strategies in high-risk prostate cancer.
Great work Joseph and Nathan, love the exploration of the literature and how to apply to patients.
Science and wit
Important messages about the relevance of the latest literature delivered with great humour and credible experts
Informative, up-to-date, funny podcasts from world leading urologists - what more could you ask for?